Sole Source Hologic HT941023N0077.pdf

PDF 77 KB Posted

Attached to
Notice of Intent to Sole Source Hologic Panther Reagents to Japan
Solicitation number
HT941023N0077
Issued by

About this file

This notice announces the intent to award a sole source contract to Hologic, Inc. for the supply of reagents and consumables used in a Hologic Panther Analyzer located at the United States Naval Hospital Yokosuka in Japan. The Defense Health Agency Contracting Activity intends to award a firm fixed price contract to Hologic, Inc. for the base year of October 1, 2023 through September 30, 2026 plus two option years. The supplies required on a quarterly basis include APTIMA COMBO 2 test kits, cleaning solution, spare caps, diagnostic caps, and disposable tips. Interested sources must submit a capability statement by August 10, 2023 demonstrating their ability to provide the required supplies to the hospital in Japan. The statement is limited to six pages using a minimum 10-point font.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Notice of Intent to Sole Source

HT941023N0077

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO

HOLOGIC, INC. The Defense Health Agency Contracting Activity (DHACA), Western Markets

Contracting Division (WMCD), San Diego, intends to award a firm fixed price Sole Source supply contract for Hologic reagents Outside the Continental of the United States (OCONUS) in support of United States Naval Hospital Yokosuka (USNHY), Japan UNDER THE

AUTHORITY OF Federal Acquisition Regulation (FAR) 13.501(a), Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:

Hologic, Inc

250 Campus DR

Marlborough, Massachusetts 01752-3020

United States

The anticipated North American Industry Classification System (NAICS) code for this requirement is 325413, In-vitro diagnostic substances manufacturing; the business size standard is 1,250 number of employees. The Product Service Code (PSC) is 6550, In vitro Diagnostic

Substances, Reagents, Test Kits, and Sets.

Supplies:

The contractor shall provide the necessary consumables for use in the government owned

Hologic Panther Analyzer aboard USNHY’s Laboratory Department. These consumables are critical supply items that enable the department to perform essential analysis to test and diagnose patients for various medical conditions and diseases.

The items required are shown below on a yearly basis.

1. 100x - PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT

2. 36x - 303085 / Lbld, Advanced Cleaning Solution, 255 mL

3. 4x - 501604 / Spare Caps, PP, 60mL, TCR APTIMA 2x50

4. 4x - CL0041 / Caps, AMP/P.R.S.(CL0045) DIAG.

5. 4x - MME-141258 / 1000‐UL DISPOSABLE TIPS WITH FILTER (CONDUCTIVE)

USNHY requires these items on a quarterly basis for a base plus 2 option years. Period of performance for deliveries will be 10/1/2023 through 9/30/2026. Delivery schedule will be as followed.

1. October Years 2023/24/25:

a. 25x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT quarterly

b. 9x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT

c. 1x - 501604 / Spare Caps, PP, 60mL, TCR APTIMA 2x50

d. 1x - CL0041 / Caps, AMP/P.R.S.(CL0045) DIAG.

e. 1x - MME-141258 / 1000‐UL DISPOSABLE TIPS WITH FILTER

(CONDUCTIVE)

2. January Years 2024/25/26

a. 25x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT quarterly

b. 9x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT

c. 1x - 501604 / Spare Caps, PP, 60mL, TCR APTIMA 2x50

d. 1x - CL0041 / Caps, AMP/P.R.S.(CL0045) DIAG.

e. 1x - MME-141258 / 1000‐UL DISPOSABLE TIPS WITH FILTER

3. April Years 2024/25/26

a. 25x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT quarterly

b. 9x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT

c. 1x - 501604 / Spare Caps, PP, 60mL, TCR APTIMA 2x50

d. 1x - CL0041 / Caps, AMP/P.R.S.(CL0045) DIAG.

e. 1x - MME-141258 / 1000‐UL DISPOSABLE TIPS WITH FILTER

4. July Years 2024/25/26

a. 25x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT quarterly

b. 9x PRD-05576 / APTIMA COMBO 2, 100‐TEST KIT

c. 1x - 501604 / Spare Caps, PP, 60mL, TCR APTIMA 2x50

d. 1x - CL0041 / Caps, AMP/P.R.S.(CL0045) DIAG.

e. 1x - MME-141258 / 1000‐UL DISPOSABLE TIPS WITH FILTER

This notice of intent is not a request for competitive quotations, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required services at United States Naval Hospital Yokosuka (USNHY), Japan. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point.

All capability statements received by the due date of this notice will be considered by the

Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the

Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.

If a vendor challenges the basis of this requirement, please email capability statements as a

Microsoft Word or Adobe PDF attachment to Pedro Reyes at pedro.a.reyes10.civ@health.mil.

The closing date for challenges is no later than 10:00am Pacific Daylight Time, 10 August 2023.

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

File details come from the government source that posted it. Updated .